Antineoplastic agents in pancreatic cancer-related c linical trials (september 2008) - Composés antinéoplasique s en essais cliniques relatifs au cancer du pancréas (septe mbre 2008)

Antineoplastic agents in pancreatic cancer-related clinical trials
(september 2008) - Composés antinéoplasiques en essais cliniques
relatifs au cancer du pancréas (septembre 2008)



Alanosine, Aldesleukin, Angiopeptin, Arsenic trioxide

BBR 3464, Bevacizumab, Bleomycin, Bortezomib, Bryostatin 1

Camptothecin, Capecitabine, Cetuximab, Cyclophosphamide

Denileukin diftitox, Dexamethasone, Docetaxel, Dolastatin 10,
Doxorubicin, DX 8951

Epothilone B, Epothilones, Etoposide, Etoposide phosphate

Flavopiridol, Floxuridine, Fludarabine, Fludarabine monophosphate,
Fluorouracil, FR 901228

Gefitinib, Gemcitabine, Genistein

Ifosfamide, Imatinib, Interferon Alfa-2a, Interferon Alfa-2b,
Interferon Type I (Recombinant), Interleukin-12, Irinotecan,
Irofulven, Isophosphamide mustard

Lanreotide, Lapatinib, Lenalidomide

Mechlorethamine, Megestrol, Megestrol Acetate, Melphalan, Mitomycins,
Motexafin gadolinium

O-(chloroacetylcarbamoyl)fumagillol, Octreotide, Oxaliplatin

Paclitaxel, Pemetrexed, Perilla alcohol, PS-K

Rituximab

Sirolimus, Sorafenib, Streptozocin, Suberoylanilide hydroxamic acid,
Sunitinib

Taxane, Temozolomide, Thalidomide, Tipifarnib, Trastuzumab,
Trimetrexate

Vapreotide

7-hydroxystaurosporine, 9-nitrocamptothecin



Info : InTextoResearch, Baelen, Wallonie (Wallonia), Belgique
(Belgium) (Marc Lacroix) & Agence Wallonne d’Information Scientifique
(AWIS)